Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1095 | 1011 | 1095 | 1119 | 1468 | 2478 |
Fund Return | 9.5% | 1.06% | 9.5% | 3.81% | 7.98% | 9.5% |
Place in category | 1658 | 1506 | 1658 | 1217 | 924 | 235 |
% in Category | 94 | 80 | 94 | 79 | 73 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Eq Cl Sr FT6 | 7.35B | 10.86 | 5.10 | 10.87 | ||
Manulife Glbl Eq Cl Sr Adv | 7.35B | 9.50 | 3.82 | 9.51 | ||
Manulife Glbl Eq Cl Sr F | 7.35B | 10.85 | 5.10 | 10.86 | ||
Manulife Div incm Fd Sr Adv | 6.83B | 15.11 | 1.45 | 8.68 | ||
Manulife Div incm Fd Sr F | 6.83B | 16.41 | 2.59 | 9.90 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 16.83B | 60.55 | 18.32 | - | ||
Capital Group Glbal Equity Fd A CAD | 14.3B | 27.06 | 4.20 | 10.67 | ||
Capital Group Glbal Equity Fd D CAD | 14.3B | 28.08 | 5.00 | 11.43 | ||
Capital Group Glbal Equity Fd F CAD | 14.3B | 28.47 | 5.35 | 11.90 | ||
Mawer Global Equity | 10.36B | 10.72 | 4.79 | 10.63 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.29 | 99.82 | -0.38% | |
Marsh McLennan | US5717481023 | 5.01 | 218.58 | +0.53% | |
UnitedHealth | US91324P1021 | 4.41 | 534.01 | +0.80% | |
Microsoft | US5949181045 | 4.21 | 444.49 | -0.50% | |
Alimentation Couche Tard | CA01626P1484 | 4.03 | 76.01 | -0.96% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review